These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8290745

  • 21. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
    Fitzgerald D, Van Asperen P, Mellis C, Honner M, Smith L, Ambler G.
    Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
    [Abstract] [Full Text] [Related]

  • 22. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily.
    Ratner PH, Paull BR, Findlay SR, Hampel F, Martin B, Kral KM, Rogenes PR.
    J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):285-91. PubMed ID: 1527313
    [Abstract] [Full Text] [Related]

  • 23. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 24. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
    Terzano C, Ricci A, Burinschi V, Nekam K, Lahovsky J.
    Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
    [Abstract] [Full Text] [Related]

  • 26. A placebo controlled trial of fluticasone propionate in asthmatic children.
    MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K.
    Eur J Pediatr; 1993 Oct; 152(10):856-60. PubMed ID: 8223792
    [Abstract] [Full Text] [Related]

  • 27. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M, Wettenger R, Gans SJ.
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma.
    Hampel FC, Carr W, Gillespie M, Small CJ.
    Allergy Asthma Proc; 2017 Nov 08; 38(6):419-430. PubMed ID: 28886758
    [Abstract] [Full Text] [Related]

  • 30. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.
    Respir Med; 2009 Jan 08; 103(1):41-9. PubMed ID: 18977646
    [Abstract] [Full Text] [Related]

  • 31. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ, Currie GP, Lipworth BJ.
    J Allergy Clin Immunol; 2002 Jun 08; 109(6):929-35. PubMed ID: 12063520
    [Abstract] [Full Text] [Related]

  • 32. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL.
    Thorax; 1995 Oct 08; 50(10):1044-50. PubMed ID: 7491551
    [Abstract] [Full Text] [Related]

  • 33. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG.
    J Asthma; 1998 Oct 08; 35(4):337-45. PubMed ID: 9669827
    [Abstract] [Full Text] [Related]

  • 34. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May 08; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 35. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group.
    Williams J, Richards KA.
    Br J Clin Pract; 1997 May 08; 51(3):147-53. PubMed ID: 9293055
    [Abstract] [Full Text] [Related]

  • 36. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
    Nathan RA, Li JT, Finn A, Jones R, Payne JE, Wolford JP, Harding SM.
    Chest; 2000 Aug 08; 118(2):296-302. PubMed ID: 10936116
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug 08; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 08; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 39. The clinical efficacy of fluticasone propionate (Fluvent) compared with beclomethasone dipropionates (Becotide) in patients with mild to moderate brochial asthma at the University College Hospital, Ibadan, Nigeria.
    Ige OM, Sogaolu OM.
    West Afr J Med; 2002 Jan 08; 21(4):297-301. PubMed ID: 12665269
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis.
    Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G.
    Ann Allergy Asthma Immunol; 1997 Mar 08; 78(3):270-6. PubMed ID: 9087151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.